Law Offices of Howard G. Smith announces that investors of Vical Incorporated (“Vical” or the “Company”) (NASDAQ:VICL) have until December 31, 2013, to move the Court to serve as lead plaintiff in the securities fraud class action lawsuit filed in the United States District Court for the Southern District of California on behalf of a class (the “Class”) comprising all purchasers of Vical securities between February 8, 2012 and August 12, 2013, inclusive (the “Class Period”).

“Allovectin simply did not provide the expected benefits”

Vical is a biopharmaceutical company that researches and develops products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening illnesses, including cancer. Vical’s lead product candidate for U.S. Food and Drug Administration marketing approval is Allovectin, an immunotherapy vaccine that targets cancer. The Complaint alleges that the Company misrepresented Allovectin’s efficacy and likelihood of success in the Phase 3 trial, and the overall current and future business prospects for Allovectin and the Company. On August 12, 2013, Vical announced the results of the Phase 3 Allovectin trial, which showed that the vaccine failed to show an improvement over chemotherapy, and since “Allovectin simply did not provide the expected benefits,” the Allovectin program would be terminated.

If you are a member of the Class described above, you have certain rights and have until December 31, 2013, to move for lead plaintiff status. To be a member of the Class you need not take any action at this time or may retain counsel of your choice. If you purchased shares prior to the Class Period and wish to learn more concerning your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.